Use of Intranasal Naloxone by Basic Life Support Providers

References

• Paulozzi LJ, Weisler RH, Patkar AA. A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J Clin Psych. 2011;72:589–92.
   Web of Science ®Google Scholar
• Jones CM, Mack KA, Paulozzi L. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309:657–9.
   PubMed Web of Science ®Google Scholar
• Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in Drug and Opioid Overdose Deaths–United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50-51):1378–82.
   PubMed Web of Science ®Google Scholar
• Webster LR, Cochella S, Dasgupta N, et al. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med. 2011;12 (Suppl 2):S26–35.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Acetyl fentanyl overdose fatalities–Rhode Island, March-May 2013. MMWR Morb Mortal Wkly Rep. 2013;62:703–4.
   PubMed Web of Science ®Google Scholar
• Stogner JM. The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl “disguised” as other opioids. Ann Emerg Med. 2014 Dec;64(6):637–9.
   PubMed Web of Science ®Google Scholar
• Armenian P, Olson A, Anaya A, Kurtz A, Ruegner R, Gerona RR. Fentanyl and a novel synthetic opioid U-47700 masquerading as street “Norco” in Central California: a case report. Ann Emerg Med. 2017 Jan;69(1):87–90.
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015 Oct 29;373(18):1789–90.
   PubMed Web of Science ®Google Scholar
• Chamberlain JM, Klein BL. A comprehensive review of naloxone for the emergency physician. Am J Emerg Med. 1994;12:650–60.
   PubMed Web of Science ®Google Scholar
• Robinson A, Wermeling DP. Intranasal naloxone administration for treatment of opioid overdose. Am J Health Syst Pharm. 2014 Dec 15;71(24):2129–35.
   PubMed Web of Science ®Google Scholar
• Ashton H, Hassan Z. Best evidence topic report. Intranasal naloxone in suspected opioid overdose. Emerg Med J. 2006;23:221–3.
   PubMed Web of Science ®Google Scholar
• Barton ED, Ramos J, Colwell C, Benson J, Baily J, Dunn W. Intranasal administration of naloxone by paramedics. Prehosp Emerg Care. 2002 Jan–Mar;6(1):54–8.
   PubMedGoogle Scholar
• Barton ED, Colwell CB, Wolfe T, et al. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. J Emerg Med. 2005 Oct;29(3):265–71.
   PubMed Web of Science ®Google Scholar
• Robertson TM, Hendey GW, Stroh G, Shalit M. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose. Prehosp Emerg Care. 2009 Oct–Dec;13(4):512–5.
   PubMed Web of Science ®Google Scholar
• Merlin MA, Saybolt M, Kapitanyan R, et al. Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses. Am J Emerg Med. 2010 Mar;28(3):296–303.
   PubMed Web of Science ®Google Scholar
• Kelly AM, Kerr D, Dietze P, Patrick I, Walker T, Koutsogiannis Z. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. Med J Aust. 2005 Jan 3;182(1):24–7.
   PubMed Web of Science ®Google Scholar
• Kerr D, Dietze P, Kelly AM. Intranasal naloxone for the treatment of suspected heroin overdose. Addiction. 2008 Mar;103(3):379–86.
   PubMed Web of Science ®Google Scholar
• Boston Emergency Medical Services Annual Report, 2011. Available at: http://www.cityofboston.gov/images_documents/2011_boston_ems_annual_report_tcm3-32900.pdf. Accessed December 8, 2016.
   Google Scholar
• Medicare Payment Advisory Commission. Chapter 7: mandated report: Medicare payment for ambulance services. In: Report to the Congress: Medicare and the Health Care Delivery System. Washington, DC: Medicare Payment Advisory Commission; 2013. Available at: http://www.medpac.gov/docs/default-source/reports/jun13_entirereport.pdf?sfvrsn=0. Accessed December 8, 2016.
   Google Scholar
• National Highway Traffic Safety Administration. EMS Workforce for the 21st Century: A National Assessment. Available at: http://healthandwelfare.idaho.gov/Portals/0/Medical/EMS/workforce_report_ems.pdf. Accessed December 8, 2016.
   Google Scholar
• Belz D, Lieb J, Rea T, Eisenberg MS. Naloxone use in a tiered-response emergency medical services system. Prehosp Emerg Care. 2006 Oct–Dec;10(4):468–71.
   PubMed Web of Science ®Google Scholar
• Sporer KA. Strategies for preventing heroin overdose. BMJ. 2003 Feb 22;326(7386):442–4.
   PubMed Web of Science ®Google Scholar
• Kim D, Irwin KS, Khoshnood K. Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. Am J Public Health. 2009;99:402–7.
   PubMed Web of Science ®Google Scholar
• Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.
   PubMed Web of Science ®Google Scholar
• Dwyer K, Walley AY, Langlois BK, et al. Opioid education and nasal naloxone rescue kits in the emergency department. West J Emerg Med. 2015 May;16(3):381–4.
   PubMed Web of Science ®Google Scholar
• Wheeler E, Jones TS, Gilbert MK, Davidson PJ; Centers for Disease Control and Prevention (CDC). Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014. MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):631–5.
   PubMed Web of Science ®Google Scholar
• Kitch BB, Portela RC. Effective use of naloxone by law enforcement in response to multiple opioid overdoses. Prehosp Emerg Care. 2016;20(2):226–9.
   PubMed Web of Science ®Google Scholar
• Davis CS, Southwell JK, Niehaus VR, Walley AY, Dailey MW. Emergency medical services naloxone access: a national systematic legal review. Acad Emerg Med. 2014 Oct;21(10):1173–7.
   PubMed Web of Science ®Google Scholar
• National Highway Traffic Safety Administration. National EMS Scope of Practice Model. Report No. DOT HS 810 657. Available at: http://www.ems.gov/education/EMSScope.pdf. Accessed December 8, 2016.
   Google Scholar
• Stone BJ, Chantler PJ, Baskett PJ. The incidence of regurgitation during cardiopulmonary resuscitation: a comparison between the bag valve mask and laryngeal mask airway. Resuscitation. 1998 Jul;38(1):3–6.
   PubMed Web of Science ®Google Scholar
• Lagu T, Anderson BJ, Stein M. Overdoses among friends: drug users are willing to administer naloxone to others. J Subst Abuse Treat. 2006 Mar;30(2):129–33.
   PubMed Web of Science ®Google Scholar
• Kerr D, Kelly AM, Dietze P, Jolley D, Barger B. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction. 2009 Dec;104(12):2067–74.
   PubMed Web of Science ®Google Scholar
• Osterwalder JJ. Naloxone—for intoxications with intravenous heroin and heroin mixtures–harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol. 1996;34(4):409–16.
   PubMed Web of Science ®Google Scholar
• Fareed A, Buchanan-Cummings AM, Crampton K, Grant A, Drexler K. Reversal of overdose on fentanyl being illicitly sold as heroin with naloxone nasal spray: A case report. Am J Addict. 2015 Aug;24(5):388–90.
   PubMed Web of Science ®Google Scholar
• Zuckerman M, Weisberg SN, Boyer EW. Pitfalls of intranasal naloxone. Prehosp Emerg Care. 2014 Oct–Dec;18(4):550–4.
   PubMed Web of Science ®Google Scholar
• Sumner SA, Mercado-Crespo MC, Spelke MB, et al. Use of naloxone by emergency medical services during opioid drug overdose resuscitation efforts. Prehosp Emerg Care. 2016;20(2):220–5.
   PubMed Web of Science ®Google Scholar
• Wampler DA, Molina DK, McManus J, Laws P, Manifold CA. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care. 2011 Jul–Sep;15(3):320–4.
   PubMed Web of Science ®Google Scholar
• Levine M, Sanko S, Eckstein M. Assessing the risk of prehospital administration of naloxone with subsequent refusal of care. Prehosp Emerg Care. 2016 Mar 28:1–4.
   Web of Science ®Google Scholar